Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,659
archived clinical trials in
Metabolic

Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated:  12/31/1969
NYU School of Medicine
mi
from
New York, NY
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated: 12/31/1969
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated:  12/31/1969
Doembecher Children's Hospital, Oregon Health and Sciences University
mi
from
Portland, OR
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated: 12/31/1969
Doembecher Children's Hospital, Oregon Health and Sciences University
mi
from
Portland, OR
Click here to add this to my saved trials
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated:  12/31/1969
Medical College of Wisconsin
mi
from
Wauwatosa, WI
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated: 12/31/1969
Medical College of Wisconsin
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated:  12/31/1969
Royal Perth Hospital
mi
from
Perth,
Clinical Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Miglustat in Patients With Stable Type 1 Gaucher Disease
Open-label, Non Comparative, Multi-center Study to Evaluate the Long Term Efficacy, Safety and Tolerability of Oral Miglustat as a Maintenance Therapy After a Switch From Enzyme Replacement Therapy in Adult Patients With Stable Type 1 Gaucher Disease
Status: Enrolling
Updated: 12/31/1969
Royal Perth Hospital
mi
from
Perth,
Click here to add this to my saved trials
Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Status: Enrolling
Updated:  12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Status: Enrolling
Updated:  12/31/1969
O&O Alpan
mi
from
Fairfax, VA
Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
O&O Alpan
mi
from
Fairfax, VA
Click here to add this to my saved trials
Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Status: Enrolling
Updated:  12/31/1969
Royal Melbourne Hospital
mi
from
Parkville,
Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry Disease
An Open-label Extension of Study TKT028 Evaluating Safety and Clinical Outcomes of Replagal® Enzyme Replacement Therapy Administered to Adult Patients With Fabry Disease
Status: Enrolling
Updated: 12/31/1969
Royal Melbourne Hospital
mi
from
Parkville,
Click here to add this to my saved trials
Effects of Growth Hormone in Chronically Ill Children
Status: Enrolling
Updated:  12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Effects of Growth Hormone in Chronically Ill Children
Status: Enrolling
Updated: 12/31/1969
Children's Medical Center of Dallas
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Regional Metabolic Center
mi
from
Los Angeles, CA
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Regional Metabolic Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Children's Hospital Oakland
mi
from
Oakland, CA
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Emory University
mi
from
Decatur, GA
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Emory University
mi
from
Decatur, GA
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Feinberg School of Medicine
mi
from
Chicago, IL
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Children's Minnesota
mi
from
Minneapolis, MN
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Children's Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Children's Mercy Hospital & Clinic
mi
from
Kansas City, MO
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Hospital & Clinic
mi
from
Kansas City, MO
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
NYU School of Medicine
mi
from
New York, NY
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
NYU School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Cincinatti Children's Hospital
mi
from
Cincinnati, OH
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Cincinatti Children's Hospital
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Medical Genetics/Pediatrics
mi
from
Salt Lake City, UT
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Medical Genetics/Pediatrics
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Children's Hospital of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated:  12/31/1969
Shaare Zedek Medical Center
mi
from
Jerusalem,
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
A Multicenter Open-Label Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Patients With Type 1 Gaucher Disease Previously Treated With Imiglucerase
Status: Enrolling
Updated: 12/31/1969
Shaare Zedek Medical Center
mi
from
Jerusalem,
Click here to add this to my saved trials
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Status: Enrolling
Updated:  12/31/1969
UT Southwestern Medical Center 5323 Harry Hines Blvd
mi
from
Dallas, TX
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Orlistat for the Treatment of Type I Hyperlipoproteinemia
Status: Enrolling
Updated: 12/31/1969
UT Southwestern Medical Center 5323 Harry Hines Blvd
mi
from
Dallas, TX
Click here to add this to my saved trials
Vascepa to Accelerate Lipoprotein Uptake and Elimination
Vascepa to Accelerate Lipoprotein Uptake and Elimination (VALUE): An Open-Label, Mechanistic, Randomized, Controlled, Single-Center Trial of AMR101 in Patients With Dyslipidemia
Status: Enrolling
Updated:  12/31/1969
Perelman School of Medicine, University of Pennsylvania
mi
from
Philadelphia, PA
Vascepa to Accelerate Lipoprotein Uptake and Elimination
Vascepa to Accelerate Lipoprotein Uptake and Elimination (VALUE): An Open-Label, Mechanistic, Randomized, Controlled, Single-Center Trial of AMR101 in Patients With Dyslipidemia
Status: Enrolling
Updated: 12/31/1969
Perelman School of Medicine, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.
Status: Enrolling
Updated:  12/1/2006
Stanford Univ Med Ctr
mi
from
Stanford, CA
Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.
Comparison Fenofibrate, Rosiglitazone, or Weight Loss to Decrease Cardiovascular Risk in Insulin Resistant Dyslipidemic Individuals.
Status: Enrolling
Updated: 12/1/2006
Stanford Univ Med Ctr
mi
from
Stanford, CA
Click here to add this to my saved trials
Oral Carnitine for Cramps in Pregnancy
Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial
Status: Enrolling
Updated:  8/14/2007
USC Perinatal Group Medical Office
mi
from
Los Angeles, CA
Oral Carnitine for Cramps in Pregnancy
Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial
Status: Enrolling
Updated: 8/14/2007
USC Perinatal Group Medical Office
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oral Carnitine for Cramps in Pregnancy
Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial
Status: Enrolling
Updated:  8/14/2007
USC Perinatal Group Medical Office
mi
from
Los Angeles, CA
Oral Carnitine for Cramps in Pregnancy
Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial
Status: Enrolling
Updated: 8/14/2007
USC Perinatal Group Medical Office
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oral Carnitine for Cramps in Pregnancy
Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial
Status: Enrolling
Updated:  8/14/2007
Women's & Children's Hospital Midwife Clinic
mi
from
Los Angeles, CA
Oral Carnitine for Cramps in Pregnancy
Oral L-Carnitine for the Treatment of Muscle Cramps in Pregnancy: A Randomized, Controlled Trial
Status: Enrolling
Updated: 8/14/2007
Women's & Children's Hospital Midwife Clinic
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Triglyceride Lowering Study
Dose Related Decrease in Triglycerides in Patients With Hypertriglyceridemia and Treated With Lovaza.
Status: Enrolling
Updated:  7/7/2009
Jewish Hospital Cholesterol Center
mi
from
Cincinnati, OH
Triglyceride Lowering Study
Dose Related Decrease in Triglycerides in Patients With Hypertriglyceridemia and Treated With Lovaza.
Status: Enrolling
Updated: 7/7/2009
Jewish Hospital Cholesterol Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
A Double-blind, Randomized, Placebo-controlled, Crossover Trial to Assess the Effects of 4 g/d Prescription Omega-3 Acid Ethyl Esters on Indices of Glucose Homeostasis and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
Status: Enrolling
Updated:  1/26/2010
Provident Clinical Research
mi
from
Addison, IL
Effects of Prescription Omega-3 Acids on Glucose and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
A Double-blind, Randomized, Placebo-controlled, Crossover Trial to Assess the Effects of 4 g/d Prescription Omega-3 Acid Ethyl Esters on Indices of Glucose Homeostasis and Lipoprotein Lipids in Subjects With Hypertriglyceridemia
Status: Enrolling
Updated: 1/26/2010
Provident Clinical Research
mi
from
Addison, IL
Click here to add this to my saved trials
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/16/2010
Veterans Administration of Greater Los Angeles Health System
mi
from
Los Angeles, CA
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/16/2010
Veterans Administration of Greater Los Angeles Health System
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/16/2010
Georgetown University
mi
from
Washington,
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/16/2010
Georgetown University
mi
from
Washington,
Click here to add this to my saved trials
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated:  2/16/2010
Johns Hopkins University
mi
from
Baltimore, MD
Omega-3 Fatty Acids for High Triglycerides in HIV-infected Patients
A Randomized, Double-Blind, Placebo-Controlled Study of N-3 Fatty Acid on Plasma Triglyceride Levels in Hypertriglyceridemic HIV Patients Receiving Highly Active Antiretroviral Therapy
Status: Enrolling
Updated: 2/16/2010
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Effects of Prescription OMega-3 Fatty Acids (Omacor®, Lovaza®) on Platelet Activity in Patients With Coronary Artery Disease With Hypertriglyceridemia (OMPA-CAD)
Status: Enrolling
Updated:  3/11/2010
Victor Serebruany
mi
from
Towson, MD
Effects of Omega-3 Fatty Acids on Platelets in Patients With Coronary Artery Disease With Hypertriglyceridemia
Effects of Prescription OMega-3 Fatty Acids (Omacor®, Lovaza®) on Platelet Activity in Patients With Coronary Artery Disease With Hypertriglyceridemia (OMPA-CAD)
Status: Enrolling
Updated: 3/11/2010
Victor Serebruany
mi
from
Towson, MD
Click here to add this to my saved trials
Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
A Randomized, Open-Label, Single- and Multiple-Dose, Four-Way Parallel Study Comparing the Fed and Fasted Pharmacokinetics of Two Dose Levels of Diazoxide Choline Controlled-Release Tablet (DCCR) in Healthy VolunteersVOLUNTEERS
Status: Enrolling
Updated:  11/4/2010
TBD
mi
from
TBD, CA
Open-Label, Single- and Multiple-Dose Pharmacokinetic Study of Diazoxide Choline
A Randomized, Open-Label, Single- and Multiple-Dose, Four-Way Parallel Study Comparing the Fed and Fasted Pharmacokinetics of Two Dose Levels of Diazoxide Choline Controlled-Release Tablet (DCCR) in Healthy VolunteersVOLUNTEERS
Status: Enrolling
Updated: 11/4/2010
TBD
mi
from
TBD, CA
Click here to add this to my saved trials
Long Term Fructose
Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance: a Double-blind, Randomized Crossover Study
Status: Enrolling
Updated:  1/31/2011
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Long Term Fructose
Investigation of Supplemental L-alanine in the Management of Dietary Fructose Intolerance: a Double-blind, Randomized Crossover Study
Status: Enrolling
Updated: 1/31/2011
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
Status: Enrolling
Updated:  4/11/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
Effect of Maraviroc on Metabolic Function in Obese Subjects (Phase I)
Status: Enrolling
Updated: 4/11/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
North America Research Institute
mi
from
Azusa, CA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
North America Research Institute
mi
from
Azusa, CA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Chrishard Medical Group
mi
from
Inglewood, CA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Chrishard Medical Group
mi
from
Inglewood, CA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
UCLA
mi
from
Los Angeles, CA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Regional Cardiology Associates
mi
from
Sacramento, CA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Regional Cardiology Associates
mi
from
Sacramento, CA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Portercare Adventist Health System
mi
from
Denver, CO
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Portercare Adventist Health System
mi
from
Denver, CO
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Georgetown University Hospital
mi
from
Washington,
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Memorial Healthcare System
mi
from
Hollywood, FL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Memorial Healthcare System
mi
from
Hollywood, FL
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Jacksonville Cardiovascular Center
mi
from
Jacksonville, FL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Jacksonville Cardiovascular Center
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Kidney & HTN Specialists of Miami
mi
from
Miami, FL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Kidney & HTN Specialists of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Naples Community Hospital
mi
from
Naples, FL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Naples Community Hospital
mi
from
Naples, FL
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
The Florida Hospital
mi
from
Orlando, FL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
The Florida Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Coastal Nephrology Associates Research
mi
from
Port Charlotte, FL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Coastal Nephrology Associates Research
mi
from
Port Charlotte, FL
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
St. Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
St. Joseph's Hospital of Atlanta
mi
from
Atlanta, GA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Joseph M. Still Research Foundation, Inc.
mi
from
Augusta, GA
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Joseph M. Still Research Foundation, Inc.
mi
from
Augusta, GA
Click here to add this to my saved trials
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated:  4/21/2011
Northwestern Memorial Hospital
mi
from
Chicago, IL
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
An Observational Prospective Registry to Identify Demographic and Clinical Characteristics of Patients Hospitalized With Euvolemic and Hypervolemic Hyponatremia and Assess the Comparative Effectiveness of Available Treatments and the Impact on Resource Utilization
Status: Enrolling
Updated: 4/21/2011
Northwestern Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials